A Treatment-Refractory, Perianal Tumor Arising in an Otherwise Healthy Older Adult Woman.

07:00 EST 12th February 2020 | BioPortfolio

Summary of "A Treatment-Refractory, Perianal Tumor Arising in an Otherwise Healthy Older Adult Woman."

No Summary Available


Journal Details

This article was published in the following journal.

Name: JAMA dermatology
ISSN: 2168-6084


DeepDyve research library

PubMed Articles [29753 Associated PubMed Articles listed on BioPortfolio]

Targeted treatment approaches in refractory germ cell tumors.

Germ cell tumors (GCTs) are the most common type of solid tumor amongst patients between 15 and 35 years of age. They are also one of the types of tumor with the highest cure rate, due to their high s...

Perianal Abscess in Infants: Amenable to Conservative Treatment in Selected Cases.

Perianal abscess is a common surgical condition in the daily pediatric practice. Management is a subject of controversy and variety of approaches are practiced. While the most frequent approach is dra...

Melanotic neuroectodermal tumor of infancy arising in the skull and brain: a systematic review.

Melanotic neuroectodermal tumor of infancy (MNTI) is rare pigmented craniofacial tumor of infants. This study aimed to analyze the published literatures on MNTI arising from the skull and brain. A sys...

Outcomes of silver nitrate use in perianal fistula: are perianal fistulas still a nightmare for surgeons?

In this study, we aimed to evaluate outcomes of % 20 silver nitrate (SNS) application in perianal fistula patients.

An "easy" method to understand perianal sepsis.

Perianal sepsis is one of the most challenging diseases for the colorectal surgeon. The management of this pathology can be associated with high morbidity. Incorrect diagnosis is quite common with con...

Clinical Trials [20529 Associated Clinical Trials listed on BioPortfolio]

Re-treatment From a Phase I Study of MSC-AFP in Patients With Perianal Fistulas

This study is an extension to re-treat partial and non-responders from the previously approved Phase 1 MCS-AFP protocols IRB #12-009716 (Crohn's Disease perianal fistulas) and 15-003200 (c...

Packing of Perianal Abscess Cavities

The aim of this trial is to compare internal wound packing to no packing in postoperative management following incision and drainage of perianal abscess. Participants will be randomised 1:...

NASHA/Dx as a Perianal Implant for the Treatment of Persistent Fecal Incontience After Anorectal Malformation

Persistent fecal incontinence (FI) after anorectal malformations (ARM) is a common occurence. During the last two decades perianal injection therapy has emerged as an option for treating p...

Evaluation of Local Co-administration of Autologous ADIpose Derived Stromal Vascular Fraction With Microfat for Refractory Perianal CROHN's Fistulas.

Autologous ADSVF constitutes an innovative therapeutic strategy that concentrates various types of regenerative stem cells and paracrine factors able to promote angiogenesis and tissue rep...

Perianal Nerval Block in Proctological Interventions

The aim of this study is to evaluate whether a local perianal block performed during a proctological intervention can reduce the postoperative pain.

Medical and Biotech [MESH] Definitions

A sarcoma of the body of the uterus arising in older women, composed of more than one mesenchymal tissue, especially including striated muscle cells. It is associated with previous pelvic radiation exposure in 20% of patients. (Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1702)

A malignant tumor arising from secreting cells of a racemose gland, particularly the salivary glands. Racemose (Latin racemosus, full of clusters) refers, as does acinar (Latin acinus, grape), to small saclike dilatations in various glands. Acinar cell carcinomas are usually well differentiated and account for about 13% of the cancers arising in the parotid gland. Lymph node metastasis occurs in about 16% of cases. Local recurrences and distant metastases many years after treatment are common. This tumor appears in all age groups and is most common in women. (Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1240; from DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p575)

Chronic refractory anemia with granulocytopenia, and/or thrombocytopenia. Myeloblasts and progranulocytes constitute 5 to 40 percent of the nucleated marrow cells.

Persistent pain that is refractory to some or all forms of treatment.

The period of time following the triggering of an ACTION POTENTIAL when the CELL MEMBRANE has changed to an unexcitable state and is gradually restored to the resting (excitable) state. During the absolute refractory period no other stimulus can trigger a response. This is followed by the relative refractory period during which the cell gradually becomes more excitable and the stronger impulse that is required to illicit a response gradually lessens to that required during the resting state.

Quick Search

DeepDyve research library

Searches Linking to this Article